Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Holt

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Antimicrobial Chemotherapy|February 28, 2002
BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobialsM Wootton, K E Bowker, H A Holt, et al.
The Journal of Antimicrobial Chemotherapy|February 28, 2002
In vitro activity of linezolid against Gram-positive isolates causing infection in continuous ambulatory peritoneal dialysis patientsK E Bowker, M Wootton, H A Holt, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 1998
Ampicillin-aminoglycoside interaction studies using Listeria monocytogenesA MacGowan, M Wootton, K Bowker, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and Streptococci of lancefield groups A and GA P MacGowan, K E Bowker, M Wootton, et al.
The American Journal of Clinical Nutrition|June 26, 2002
International table of glycemic index and glycemic load values: 2002Kaye Foster-Powell, Susanna H A Holt, Janette C Brand-Miller
Antimicrobial Agents and Chemotherapy|July 2, 1999
Activity of moxifloxacin, administered once a day, against Streptococcus pneumoniae in an in vitro pharmacodynamic model of infectionA P MacGowan, K E Bowker, M Wootton, et al.
The Journal of Antimicrobial Chemotherapy|July 7, 2000
Assessment of different antibacterial effect measures used in in vitro models of infection and subsequent use in pharmacodynamic correlations for moxifloxacinA MacGowan, C Rogers, H A Holt, et al.
Infection|January 1, 1976
Interactions between aminoglycoside antibiotics and carbenicillin or ticarillinH A Holt, J M Broughall, M McCarthy, et al.
The Journal of Nutrition|July 31, 2003
The degree of fat saturation does not alter glycemic, insulinemic or satiety responses to a starchy staple in healthy menCaroline G MacIntosh, Susanna H A Holt, Jennie C Brand-Miller
Arzneimittel-Forschung|January 1, 1979
Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibioticsD S Reeves, M J Bywater, H A Holt, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|February 28, 2002
BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobialsM Wootton, K E Bowker, H A Holt, et al.
The Journal of Antimicrobial Chemotherapy|February 28, 2002
In vitro activity of linezolid against Gram-positive isolates causing infection in continuous ambulatory peritoneal dialysis patientsK E Bowker, M Wootton, H A Holt, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 1998
Ampicillin-aminoglycoside interaction studies using Listeria monocytogenesA MacGowan, M Wootton, K Bowker, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and Streptococci of lancefield groups A and GA P MacGowan, K E Bowker, M Wootton, et al.
The American Journal of Clinical Nutrition|June 26, 2002
International table of glycemic index and glycemic load values: 2002Kaye Foster-Powell, Susanna H A Holt, Janette C Brand-Miller
Antimicrobial Agents and Chemotherapy|July 2, 1999
Activity of moxifloxacin, administered once a day, against Streptococcus pneumoniae in an in vitro pharmacodynamic model of infectionA P MacGowan, K E Bowker, M Wootton, et al.
The Journal of Antimicrobial Chemotherapy|July 7, 2000
Assessment of different antibacterial effect measures used in in vitro models of infection and subsequent use in pharmacodynamic correlations for moxifloxacinA MacGowan, C Rogers, H A Holt, et al.
Infection|January 1, 1976
Interactions between aminoglycoside antibiotics and carbenicillin or ticarillinH A Holt, J M Broughall, M McCarthy, et al.
The Journal of Nutrition|July 31, 2003
The degree of fat saturation does not alter glycemic, insulinemic or satiety responses to a starchy staple in healthy menCaroline G MacIntosh, Susanna H A Holt, Jennie C Brand-Miller
Arzneimittel-Forschung|January 1, 1979
Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibioticsD S Reeves, M J Bywater, H A Holt, et al.
Pageof 9